News
New research shows changes to microbes in the gut can be detected before Parkinson’s symptoms appear.
The therapy has been given conditional, limited approval for people in Japan based on the results of a 2-year research study.
A £1.7 million partnership will combine data from over 20,000 people to accelerate the search for new treatments for Parkinson’s.
This International Women’s Day, we're celebrating 3 remarkable women making a real difference for people with Parkinson’s. Reflecting the theme Give to Gain, their leadership, skills and passion help the Parkinson’s community thrive.
Herantis Pharma Plc to receive almost £7 million from the European Union for a phase 2 trial of HER-096 that has the potential to slow or stop Parkinson’s.
New recommendations aim to improve the design of research trials involving brain surgery and support for participants.
3 leading researchers have now been appointed to help kick start our new research centre unlocking new ideas for treating Parkinson’s.
We funded research to identify tools that can help healthcare professionals spot delirium early in people with Parkinson’s in hospital, leading the way for more people getting the right treatment and support.
The newly funded projects explore different underlying causes of Parkinson’s, and work towards new drugs to treat the condition.
In this round of grants, we’ve awarded funding to 2 projects that explore new solutions to manage Parkinson’s symptoms, without the need for extra medication.